8-K: P3 Health Partners Announces First Quarter 2025 Results, Affirms 2025 Guidance

P3 Health Partners reported its Q1 2025 financial results, showing a mix of decreased revenue and membership but affirmed its 2025 guidance, highlighting progress in its turnaround plan.

Summary

• P3 Health Partners announced its financial results for the first quarter ended March 31, 2025.
• The company affirmed its 2025 guidance.
• Average at-risk membership decreased by 8% to 115,900 members compared to the prior year.
• Per-member funding (PMPM) increased by 8% to $1,063 compared to full year 2024.
• Total revenue decreased by 4% to $373.2 million compared to $388.5 million in the first quarter of the prior year.
• Medical margin was $17.2 million compared to $36.6 million in the first quarter of the prior year, including a negative $23 million net impact from prior year claims related to a single payer.
• Adjusted EBITDA loss was $22.2 million compared to an Adjusted EBITDA loss of $19.8 million in the first quarter of the prior year, including a negative $9 million net impact from prior year claims and retroactive adjustments related to a single payer.
• The company's 2025 guidance includes at-risk members between 109,000 and 119,000, total revenues between $1.35 billion and $1.5 billion, medical margin between $174 million and $210 million, and adjusted EBITDA between $(35) million and $5 million.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company affirms its guidance, key metrics like revenue and membership are down, and losses persist. The positive comments from management are balanced by the financial results.

Positives

• Per-member funding (PMPM) increased by 8% to $1,063, indicating higher revenue per member.
• The company affirmed its 2025 guidance, suggesting confidence in future performance.
• Three of four markets are already achieving breakeven or better in Q1.
• The company has identified additional value creation opportunities through enhanced complex care programs and payment integrity initiatives.

Negatives

• Average at-risk membership decreased by 8% to 115,900 members.
• Total revenue decreased by 4% to $373.2 million.
• Medical margin decreased to $17.2 million, impacted by a negative $23 million from prior year claims.
• Adjusted EBITDA loss increased to $22.2 million, impacted by a negative $9 million from prior year claims.

Risks

• The company's ability to achieve or maintain profitability is a risk.
• Changes in market or industry conditions, regulatory environment, and competitive conditions could impact results.
• The company's ability to maintain relationships with health plans and other key payors is a risk.
• Fluctuations in risk adjustments could impact financial performance.
• Increased labor costs and medical expenses could negatively affect profitability.
• The company's ability to recruit and retain qualified team members and independent physicians is a risk.

Future Outlook

The company affirmed its 2025 guidance, projecting at-risk members between 109,000 and 119,000, total revenues between $1.35 billion and $1.5 billion, medical margin between $174 million and $210 million, and adjusted EBITDA between $(35) million and $5 million.

Management Comments

• Aric Coffman, CEO of P3, stated that the company's physician-led care enablement model continues to differentiate P3, delivering meaningful improvements in quality measures and cost management.
• Aric Coffman mentioned that the turnaround plan is ahead of schedule, with three of four markets already achieving breakeven or better in Q1.
• Aric Coffman noted that the company has identified additional value creation opportunities through enhanced complex care programs and payment integrity initiatives.
• Aric Coffman stated the company remains committed to its long-term strategic vision, making targeted investments in technology infrastructure and innovative clinical programs.

Industry Context

P3 Health Partners operates in the population health management sector, which focuses on improving patient outcomes and lowering costs through value-based care models. The company's performance is influenced by factors such as changes in healthcare regulations, competition from other healthcare providers, and the ability to manage medical costs effectively.

Comparison to Industry Standards

• Comparing P3 Health Partners to companies like Oak Street Health (before its acquisition by CVS Health) or Alignment Healthcare, which also focus on value-based care for Medicare Advantage patients, reveals some differences.
• While P3's revenue per member is increasing, its membership growth is lagging compared to some competitors in the past.
• Medical margin performance is also weaker, suggesting challenges in managing medical costs effectively compared to industry benchmarks.
• However, the company's focus on physician-led care and targeted investments in technology could provide a competitive advantage in the long run.

Stakeholder Impact

• Shareholders may be concerned about the decreased revenue and membership, as well as the increased losses.
• Employees may be affected by the company's turnaround plan and strategic investments.
• Patients may benefit from the company's focus on improving quality measures and care coordination.
• Providers may be impacted by the company's value-based care coordination and administrative services.
• Payors may be affected by the company's ability to manage medical costs effectively.

Next Steps

• Management will host a conference call and webcast on May 15, 2025, to discuss the results.
• The company will continue to execute its turnaround plan and focus on strategic investments in technology and clinical programs.

Key Dates

Keywords

financial results, P3 Health Partners, population health management, at-risk membership, medical margin, adjusted EBITDA, revenue, guidance